Mario Otto, MD, PhD, was recently awarded $100,000 from the Midwest Athletes Against Childhood Cancer (MACC fund) for “Development of Multifunctional Superparamagnetic anti-GD2 Nanoparticles for Simultaneous Molecular Imaging, Cancer Cell Targeting and Drug Delivery.” This project aims to specifically develop multifunctional superparamagnetic nanoparticles suitable to target GD2 positive malignancies. Knowledge and expertise gained from this project has the potency to lead to a nanoparticle-based platform for other applications which Dr. Otto plans to develop in the future, such as targeted drug delivery, or MR-induced, nanoparticle-mediated local hyperthermia.